References
  1. Dramburg S, Hilger C, Santos AF, de Las Vecillas L, Aalberse RC, Acevedo N, et al. EAACI Molecular Allergology User’s Guide 2.0. Pediatr Allergy Immunol. 2023 Mar;34 Suppl. 28:e13854.
  2. Acevedo N, Zakzuk J, Caraballo L. House Dust Mite Allergy Under Changing Environments. Allergy Asthma Immunol Res. 2019 Jul;11(4):450-469.
  3. González-Pérez R, Poza-Guedes P, Pineda F, Castillo M, Sánchez-Machín I. Storage Mite Precision Allergy Molecular Diagnosis in the Moderate-to-Severe T2-High Asthma Phenotype. Int J Mol Sci. 2022 Apr 13;23(8):4297.
  4. Demoly P, Passalacqua G, Pfaar O, Sastre J, Wahn U. Management of the polyallergic patient with allergy immunotherapy: a practice-based approach. Allergy Asthma Clin Immunol. 2016 Jan 11;12:2.
  5. Ojeda P, Sastre J, Olaguibel JM, Chivato T; investigators participating in the National Survey of the Spanish Society of Allergology and Clinical Immunology Alergológica 2015. Alergológica 2015: A National Survey on Allergic Diseases in the Adult Spanish Population. J Investig Allergol Clin Immunol. 2018 Jun;28(3):151-164.
  6. Alvaro-Lozano M, Akdis CA, Akdis M, Alviani C, Angier E, Arasi S, et al. EAACI Allergen Immunotherapy User’s Guide. Pediatr Allergy Immunol. 2020 May;31 Suppl 25(Suppl 25):1-101.
  7. Chen KW, Zieglmayer P, Zieglmayer R, Lemell P, Horak F, Bunu CP, Valenta R, Vrtala S. Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy. J Allergy Clin Immunol. 2019 Mar;143(3):1248-1252.e12.